Genre: Technical Report / Recently Added: Within 6 Months - Digital Collections - National Library of Medicine Search Results

1. Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Biological Products
Drug Industry
Government Regulation
Pharmaceutical Preparations
Randomized Controlled Trials as Topic
United States

2. FDA oversight

Author(s):: White, Robert S., (Compliance attorney and member of the Oklahoma Bar), author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Drug Approval -- legislation & jurisprudence
Government Regulation
Legislation, Drug
Drug-Related Side Effects and Adverse Reactions
Illicit Drugs
United States
United States. Food and Drug Administration

3. Cost savings

Author(s):: Steiner, David J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Cost Savings -- legislation & jurisprudence
Drug Costs -- legislation & jurisprudence
State Government
United States

18. Medical malpractice and tort reform

Author(s):: White, Robert, (Compliance attorney and member of the Oklahoma bar), author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Federal Government
Liability, Legal
Malpractice -- legislation & jurisprudence
State Government
United States

19. Medical errors and patient safety

Author(s):: Karberg, Jeffrey, author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Federal Government
Government Regulation
Medical Errors -- prevention & control
Patient Safety -- legislation & jurisprudence
Safety Management -- legislation & jurisprudence
Health Facilities -- legislation & jurisprudence
State Government
United States

20. Quality of healthcare

Author(s):: Brude, Sydney, author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Government Regulation
Quality of Health Care -- organization & administration
State Government
COVID-19
Nursing Homes
United States

21. Healthcare information technology

Author(s):: Fleming, Julie A., (Compliance attorney and member of the Minnesota bar), author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Electronic Health Records -- legislation & jurisprudence
Medical Informatics -- legislation & jurisprudence
State Government
United States

22. Healthcare workforce

Author(s):: White, Robert, (Compliance attorney and member of the Oklahoma bar), author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Government Regulation
Health Workforce -- legislation & jurisprudence
State Government
Dentists -- legislation & jurisprudence
Nurses -- legislation & jurisprudence
Licensure -- legislation & jurisprudence
Pharmacists -- legislation & jurisprudence
Physicians -- legislation & jurisprudence
United States

23. Healthcare facilities

Author(s):: Raduege, Tammy, author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Health Facility Administration
Medicaid -- economics
Medicare -- economics
United States

24. International healthcare

Author(s):: Berry, Melissa D., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Delivery of Health Care
Global Health
Internationality

25. Business of healthcare

Author(s):: Berry, Melissa D., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: COVID-19 Vaccines
Delivery of Health Care -- legislation & jurisprudence
Health Care Sector -- legislation & jurisprudence
Quality of Health Care -- legislation & jurisprudence
Vaccination -- legislation & jurisprudence
State Government
United States

26. Business of health insurance

Author(s):: Berry, Melissa D., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Delivery of Health Care -- legislation & jurisprudence
Insurance Coverage -- legislation & jurisprudence
Insurance, Health -- legislation & jurisprudence
Sexual and Gender Minorities -- legislation & jurisprudence
State Government
United States

27. State Children's Health Insurance Program (SCHIP)

Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Insurance Coverage -- legislation & jurisprudence
Insurance, Health -- legislation & jurisprudence
State Government
United States
State Children's Health Insurance Program (U.S.)

28. Access to health insurance

Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Health Services Accessibility -- legislation & jurisprudence
Insurance Coverage -- legislation & jurisprudence
Insurance, Health -- legislation & jurisprudence
United States

29. Medicare Part D

Author(s):: Steiner, David J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Drug Costs -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

30. Medical devices

Author(s):: White, Robert S., (Compliance Attorney and member of the Oklahoma Bar), author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Device Approval
Product Surveillance, Postmarketing
Equipment Safety
Medical Device Recalls -- legislation & jurisprudence
United States
United States. Food and Drug Administration

31. Testing of glycerin, propylene glycol, maltitol solution, hydrogenated starch hydrolysate, sorbitol solution, and other high-risk drug components for diethylene glycol and ethylene glycol: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Drug Contamination
Drug Industry
Drug-Related Side Effects and Adverse Reactions
Ethylene Glycols
Glycerol
Government Regulation
Propylene Glycol
Sorbitol
United States

32. Q9(R1): : quality risk management : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Drug Development
Drug Industry
Government Regulation
Risk Management
United States

33. Smoking cessation and related indications: developing nicotine replacement therapy drug products : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Drug Development
Government Regulation
Nicotine Chewing Gum
Smoking Cessation
Smoking Cessation Agents
Tobacco Use Cessation Devices
United States

34. S12 nonclinical biodistribution considerations for gene therapy products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Genetic Therapy
Government Regulation
Research Design
United States

35. Emergency care

Author(s):: Steiner, David J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Emergency Medical Services -- economics
Emergency Medical Services -- legislation & jurisprudence
State Government
COVID-19
Healthcare Disparities
Opioid-Related Disorders
Rural Health Services -- legislation & jurisprudence
Veterans
United States

36. Peripheral percutaneous transluminal angioplasty (PTA) and specialty catheters: premarket notification (510(k)) submissions : guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, April 14, 2023
Subject(s):: Angioplasty, Balloon, Coronary
Cardiac Catheters
Device Approval
Government Regulation
United States

37. Medicaid waivers

Author(s):: Mortenson, Logan C., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Medicaid -- legislation & jurisprudence
State Government
Community Health Services -- legislation & jurisprudence
Health Care Reform -- legislation & jurisprudence
Mental Health Services -- legislation & jurisprudence
United States

38. A risk-based approach to monitoring of clinical investigations questions and answers: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, April 2023
Subject(s):: Clinical Trials Data Monitoring Committees
Clinical Trials as Topic
Government Regulation
Research Design
Research Personnel
United States

39. Cybersecurity in medical devices: refuse to accept policy for cyber devices and related systems under section 524B of the FD&C Act : guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, March 30, 2023
Subject(s):: Computer Security -- legislation & jurisprudence
Device Approval
Equipment Safety
Government Regulation
United States
United States.

40. Soft (hydrophilic) daily wear contact lenses: performance criteria for safety and performance based pathway : guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, March 28, 2023
Subject(s):: Contact Lenses, Hydrophilic -- standards
Device Approval
Equipment Safety
Government Regulation
United States

41. General considerations for animal studies intended to evaluate medical devices: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, March 28, 2023
Subject(s):: Animal Experimentation
Animal Welfare
Animals, Laboratory
Device Approval
Equipment Safety
Equipment and Supplies
Government Regulation
United States

42. Medicaid restructuring

Author(s):: Raduege, Tammy J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Federal Government
Medicaid -- organization & administration
State Government
United States
United States.

43. Medicaid reimbursement

Author(s):: Berry, Melissa D., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Federal Government
Insurance, Health, Reimbursement -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
State Government
United States

44. Transition plan for medical devices that fall within enforcement policies issued during the coronavirus disease 2019 (COVID-19) public health emergency: guidance for industry, other stakeholders, and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, March 27, 2023
Subject(s):: Equipment and Supplies
Government Regulation
Medical Device Legislation
COVID-19
United States
United States. Food and Drug Administration

45. Medicaid provider tax

Author(s):: Fleming, Julie A., (Compliance attorney and member of the Minnesota bar), author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Federal Government
Medicaid -- legislation & jurisprudence
State Government
Taxes -- legislation & jurisprudence
United States

46. Transition plan for medical devices issued emergency use authorizations (EUAs) related to coronavirus disease 2019 (COVID-19): guidance for industry, other stakeholders, and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, March 27, 2023
Subject(s):: Equipment and Supplies
Government Regulation
Medical Device Legislation
COVID-19
United States
United States. Food and Drug Administration

47. Federal Medicaid policy

Author(s):: Raduege, Tammy J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Federal Government
Health Policy -- legislation & jurisprudence
Medicaid -- organization & administration
Community Health Services
COVID-19
Maternal Health Services
Mental Health Services
Social Determinants of Health
United States

48. Enforcement policy for face masks and barrier face coverings during the coronavirus disease (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, March 13, 2023
Subject(s):: COVID-19 -- prevention & control
Government Regulation
Masks -- standards
Medical Device Legislation
Personal Protective Equipment
United States
United States. Food and Drug Administration

49. Enforcement policy for face shields, surgical masks, and respirators during the coronavirus disease (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, March 13, 2023
Subject(s):: COVID-19 -- prevention & control
Government Regulation
Masks -- standards
Medical Device Legislation
N95 Respirators -- standards
Personal Protective Equipment
Respiratory Protective Devices -- standards
United States
United States. Food and Drug Administration

50. Medicaid eligibility

Author(s):: Mortenson, Logan C., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Eligibility Determination -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
State Government
United States
United States.

51. Definitions of suspect product and illegitimate product for verification obligations under the Drug Supply Chain Security Act: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, March 2023
Subject(s):: Drug Industry
Legislation, Drug
Drug Packaging
Drug and Narcotic Control
Government Regulation
United States

52. Evaluation of gastric pH-dependent drug interactions with acid-reducing agents: study design, data analysis, and clinical implications : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, March 2023
Subject(s):: Drug Industry
Drug Interactions
Gastrointestinal Agents
Government Regulation
Hydrogen-Ion Concentration
United States

53. Q13 continuous manufacturing of drug substances and drug products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, March 2023
Subject(s):: Biological Products
Drug Compounding
Drug Development
Drug Industry
Government Regulation
United States

54. Compounding certain ibuprofen oral suspension products under section 503B of the Federal Food, Drug, and Cosmetic Act

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, April 2023
Subject(s):: Administration, Oral
Drug Compounding -- methods
Drug Compounding -- standards
Drug Industry
Government Regulation
Ibuprofen
Legislation, Drug
Suspensions
United States
United States. Food and Drug Administration
United States.

55. Medicaid copayments

Author(s):: Berry, Melissa D., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Deductibles and Coinsurance -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
State Government
United States

56. Benefits and Services

Author(s):: Raduege, Tammy J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: Federal Government
Insurance Benefits -- legislation & jurisprudence
Medicaid -- economics
Medicaid -- legislation & jurisprudence
State Government
Community Health Services -- legislation & jurisprudence
Dental Health Services -- legislation & jurisprudence
Home Care Services -- legislation & jurisprudence
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Mental Health Services -- legislation & jurisprudence
Women's Health Services -- legislation & jurisprudence
United States

57. Oncology drug products used with certain in vitro diagnostic tests: pilot program : guidance for industry, clinical laboratories, and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, June 20, 2023
Subject(s):: Antineoplastic Agents
Drug Industry
Government Regulation
In Vitro Techniques
United States
United States. Food and Drug Administration

58. Content of premarket submissions for device software functions: guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, June 14, 2023
Subject(s):: Device Approval
Government Regulation
Software -- legislation & jurisprudence
Software -- standards
Software Design
United States

59. Clinical drug interaction studies with combined oral contraceptives: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, June 2023
Subject(s):: Contraceptives, Oral
Drug Evaluation
Drug Industry
Drug Interactions
Government Regulation
United States

60. Cover letter attachments for controlled correspondence and ANDA submissions: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, June 2023
Subject(s):: Correspondence as Topic
Drug Approval
Drug Industry
Drugs, Generic
Government Regulation
United States
United States. Food and Drug Administration

61. Wildfires

Author(s):: Campbell, Sheila (Sheila Marie), author
Kile, Joseph, author
Publication:: [Washington, D.C.] : Congressional Budget Office, June 2022
Subject(s):: Budgets
Federal Government
Wildfires -- economics
Wildfires -- statistics & numerical data
Environmental Pollution -- adverse effects
Smoke -- adverse effects
Wildfires -- prevention & control
United States

62. Nonclinical evaluation of the immunotoxic potential of pharmaceuticals: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, June 2023
Subject(s):: Drug Evaluation, Preclinical
Drug Industry
Government Regulation
Pharmaceutical Preparations
Toxicity Tests
United States

63. CBO’s 2023 long-term projections for Social Security

Author(s):: Cheng, Xinzhe, author
Dahl, Molly W., author
Topoleski, Julie H., author
Publication:: [Washington, D.C.] : Congressional Budget Office, June 2023
Subject(s):: Forecasting
Social Security -- economics
Social Security -- trends
United States

64. Long-term projections of health care spending and the implications for the federal budget: presentation at the 15th annual meeting of the OECD’s working party of parliamentary budget officials and independent fiscal institutions

Author(s):: Topoleski, Julie H., author
Publication:: [Washington, D.C.] : Congressional Budget Office, April 13, 2023
Subject(s):: Budgets -- trends
Federal Government
Forecasting
Health Care Costs -- trends
Health Expenditures -- trends
United States
Organisation for Economic Co-operation and Development.

65. Drug-drug interaction assessment for therapeutic proteins: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, June 2023
Subject(s):: Cytokines
Drug Industry
Drug Interactions
Government Regulation
United States

66. Action level for inorganic arsenic in apple juice: guidance for industry

Publication:: College Park, MD : Center for Food Safety and Applied Nutrition, June 2023
Subject(s):: Arsenic
Food Safety
Food Supply
Government Regulation
United States

67. The Medicare and Medicaid Improvement Funds: budgetary history and projections

Author(s):: Hammond, Stuart, (Of Congressional Budget Office), author
Krupen, Russell, author
Publication:: [Washington, D.C.] : Congressional Budget Office, April 2023
Subject(s):: Budgets
Medicaid -- economics
Medicaid -- history
Medicaid -- trends
Medicare -- economics
Medicare -- history
Medicare -- trends
United States

68. Social Security's finances: testimony before the Subcommittee on Social Security, Committee on Ways and Means, U.S. House of Representatives

Publication:: [Washington, D.C.] : Congressional Budget Office, April 26, 2023
Subject(s):: Social Security -- economics
Social Security -- statistics & numerical data
Social Security -- trends
United States

69. Budgetary effects of policies to modify or eliminate Medicaid’s institutions for mental diseases exclusion

Author(s):: Duchovny, Noelia Judith, author
Hammond, Stuart, (Of Congressional Budget Office), author
Mutter, Ryan, 1976- author
Publication:: [Washington, D.C.] : Congressional Budget Office, April 2023
Subject(s):: Budgets
Federal Government
Health Expenditures -- statistics & numerical data
Medicaid -- economics
Mental Health Services -- economics
State Government
United States

70. The foreign-born population, the U.S. economy, and the federal budget

Publication:: [Washington, D.C.] : Congressional Budget Office, April 2023
Subject(s):: Budgets
Emigrants and Immigrants -- statistics & numerical data
Federal Government
Public Assistance -- statistics & numerical data
Workforce -- statistics & numerical data
Taxes
United States

71. Non-clinical performance assessment of tissue containment systems used during power morcellation procedures: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, May 26, 2023
Subject(s):: Device Approval
Government Regulation
Morcellation -- instrumentation
Morcellation -- legislation & jurisprudence
Morcellation -- standards
United States

72. Requirements for additional traceability records for certain foods: what you need to know about the FDA regulation : guidance for industry : small entity compliance guide

Publication:: College Park, MD : Center for Food Safety and Applied Nutrition, May 2023
Subject(s):: Food Industry
Food Labeling
Food Packaging
Food Safety
Food Supply
Government Regulation
Legislation, Food
United States

73. Implementation of acceptable full-length and abbreviated donor history questionnaires and accompanying materials for use in screening donors of blood and blood components: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2023
Subject(s):: Blood Donation
Blood Donors
Donor Selection
Government Regulation
Mandatory Testing
Surveys and Questionnaires
United States

74. Recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of human immunodeficiency virus transmission by blood and blood products: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2023
Subject(s):: Blood Donation
Blood Donors
Blood Transfusion
Donor Selection
Government Regulation
HIV Infections -- prevention & control
Mandatory Testing
United States

75. Chronic rhinosinusitis with nasal polyps: developing drugs for treatment : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, June 2023
Subject(s):: Drug Development
Drug Industry
Government Regulation
Nasal Polyps -- drug therapy
Sinusitis -- drug therapy
United States

76. Presenting quantitative efficacy and risk information in direct-to-consumer (DTC) promotional labeling and advertisements: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, June 2023
Subject(s):: Direct-to-Consumer Advertising -- legislation & jurisprudence
Direct-to-Consumer Advertising -- standards
Disclosure
Drug Industry
Drug Labeling -- legislation & jurisprudence
Drug Labeling -- standards
Government Regulation
United States

77. Alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, June 2023
Subject(s):: Biological Products -- standards
Blood Platelets
Government Regulation
Platelet Transfusion
Refrigeration
United States

78. Informed consent. Guidance for IRBs, clinical investigators, and sponsors

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):: Ethics Committees, Research
Government Regulation
Informed Consent
Research Personnel
United States
United States. Food and Drug Administration

79. Waivers, exceptions, and exemptions from the requirements of section 582 of the Federal Food, Drug, and Cosmetic Act: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):: Drug Industry
Government Regulation
Legislation, Drug
United States
United States. Food and Drug Administration
United States.

80. Hydrogen peroxide-based contact lens care products: consumer labeling recommendations : premarket notification (510(k)) submissions : guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, July 27, 2023
Subject(s):: Contact Lens Solutions
Device Approval
Government Regulation
Hydrogen Peroxide
Product Labeling
United States
United States. Food and Drug Administration

81. CDER’s program for the recognition of voluntary consensus standards related to pharmaceutical quality: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, July 2023
Subject(s):: Drug Industry
Government Regulation
Quality Control
Reference Standards
United States
United States. Food and Drug Administration

82. M7(R2) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, July 2023
Subject(s):: Carcinogens
Drug Contamination -- prevention & control
Drug Development
Drug Industry
Government Regulation
Mutagenicity Tests
Mutagens
United States
United States. Food and Drug Administration

83. The financial stability of America’s hospitals and health systems is at risk as the costs of caring continue to rise

Publication:: [Washington, D.C.] : American Hospital Association, April 2023
Subject(s):: Economics, Hospital -- statistics & numerical data
Economics, Hospital -- trends
Hospital Costs -- statistics & numerical data
Hospital Costs -- trends
Equipment and Supplies, Hospital -- economics
Personnel, Hospital -- economics
United States

84. Effective strategies for sustaining and optimizing telehealth in primary care

Author(s):: Carder, Danielle, author
Furrow-White, Courtney, author
Publication:: Washington, DC : Association of American Medical Colleges ; Irving, Texas : Vizient, March 2023
Subject(s):: Primary Health Care
Telemedicine
Diffusion of Innovation
Patient-Centered Care
United States

85. Understanding coverage considerations for COVID-19 vaccines and treatments

Author(s):: Beleche, Trinidad, author
Bush, Laina, author
Finegold, Kenneth, 1957- author
Manocchio, Teresa, author
Pyda, Sarada, author
Samson, Lok Wong, author
Sommers, Benjamin D., author
Publication:: Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, May 2023
Subject(s):: Cost Savings
COVID-19 Drug Treatment
COVID-19 -- economics
COVID-19 Vaccines -- economics
Insurance Coverage
United States

86. Updated national survey trends in telehealth utilization and modality (2021-2022)

Author(s):: Lee, Euny C., author
Grigorescu, Violanda, author
Enogieru, Idia, author
Smith, Scott R., author
Samson, Lok Wong, author
Conmy, Ann B., author
De Lew, Nancy, author
Publication:: Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, April 19, 2023
Subject(s):: Facilities and Services Utilization -- statistics & numerical data
Telemedicine -- statistics & numerical data
Telemedicine -- trends
Videoconferencing -- statistics & numerical data
Videoconferencing -- trends
United States

87. American perspectives on racism and racial justice

Author(s):: Fox, Cruz, author
Schleifer, David, author
Publication:: [Brooklyn, New York] : Public Agenda, 2023
Subject(s):: Ethnicity
Politics
Racial Groups
Racism
Religion
Social Justice
Spirituality
Public Opinion
Surveys and Questionnaires
United States

88. Training the primary care workforce to deliver team based care in underserved areas: the teaching health center program

Author(s):: Hawes, Emily, author
Rains, Jacob, author
Chen, Candice, author
Fraher, Erin P., author
Publication:: New York, NY : Milbank Memorial Fund, June 2023
Subject(s):: Education, Medical, Graduate
Health Workforce
Medically Underserved Area
Patient Care Team
Primary Health Care
Community Health Centers
Hospitals, Teaching
United States

89. Assessing the effectiveness of policies to improve access to primary care for underserved populations: case study analysis : Kanawha County, West Virginia

Author(s):: Kona, Maanasa, author
Clark, Jalisa, author
Walsh-Alker, Emma, author
Houston, Megan, author
Publication:: New York, NY : Milbank Memorial Fund, June 2023
Subject(s):: Health Services Accessibility
Medically Underserved Area
Primary Health Care
Health Workforce
Rural Population
West Virginia

90. Uninsured adults by county for the year 2020: a 2023 review of Mississippi-level 2020 data

Publication:: Ridgeland, MS : Center for Mississippi Health Policy, March 2023
Subject(s):: Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Local Government
Medically Uninsured -- statistics & numerical data
Adult
Middle Aged
Mississippi
United States

91. 2023 legislative session: a review of health-related bills & their impact

Publication:: Ridgeland, MS : Center for Mississippi Health Policy, July 2023
Subject(s):: Delivery of Health Care -- legislation & jurisprudence
Legislation as Topic
Mississippi
United States

92. Catalyzing Medicaid policy research with T-MSIS Analytic Files (TAF): learnings from year 1 of the Medicaid Data Learning Network (MDLN)

Author(s):: Gordon, Sarah, (Of Boston University), author
Johnson, Annaliese, author
Kennedy, Susan, (Of AcademyHealth), author
McConnel, John, (Of Oregon Health & Science University), author
Schpero, William, author
Publication:: Washington, DC : AcademyHealth, May 15, 2023
Subject(s):: Datasets as Topic
Health Policy
Health Services Research
Medicaid -- statistics & numerical data
Ethnicity
Fee-for-Service Plans
Health Expenditures
Information Storage and Retrieval
Managed Care Programs
Maternal Health
Opioid-Related Disorders -- drug therapy
Racial Groups
Reproductive Health
Utilization Review
United States

93. Medicaid in midlife: a profile of enrollees ages 50 to 64

Author(s):: McSpadden, James, author
Siegel, Sari, author
Publication:: Washington, DC : AARP Public Policy Institute, July 2023
Subject(s):: Ethnicity -- statistics & numerical data
Medicaid -- statistics & numerical data
Middle Aged
Racial Groups -- statistics & numerical data
Disabled Persons
Dual MEDICAID MEDICARE Eligibility
Eligibility Determination
State Government
United States

94. Medication literacy series: medication management

Author(s):: McSpadden, James, author
Publication:: Washington, DC : AARP Public Policy Institute, June 2023
Subject(s):: Medication Therapy Management
Patient Medication Knowledge
United States

95. Over 9 million adults ages 50 and older faced food insecurity in 2021

Author(s):: Dean, Olivia, author
Figueiredo, Carlos, (Of AARP Public Policy Institute), author
Publication:: Washington, DC : AARP Public Policy Institute, July 2023
Subject(s):: Aged
Food Insecurity
Ethnicity
Middle Aged
Racial Groups
Social Determinants of Health
Socioeconomic Factors
State Government
United States

96. Prices for top Medicare Part D drugs have more than tripled since entering the market

Author(s):: Purvis, Leigh, author
Publication:: Washington, DC : AARP Public Policy Institute, August 2023
Subject(s):: Drug Costs -- statistics & numerical data
Drug Costs -- trends
Medicare Part D -- economics
United States

97. It leaves me feeling defeated: searching for in-network mental health care with marketplace insurance

Author(s):: Silliman, Rebecca, author
McNally, Erin, author
Vargas-Sullivan, Cruz, author
Schleifer, David, author
Publication:: [Brooklyn, New York] : Public Agenda, 2023
Subject(s):: Health Insurance Exchanges
Health Services Accessibility
Insurance Coverage
Medically Underserved Area
Mental Health Services
United States

98. Social needs screening among non-federal acute care hospitals, 2022

Author(s):: Chang, Wei, (Of United States. Department of Health and Human Services. Office of the National Coordinator for Health Information Technology), author
Richwine, Chelsea J., author
Publication:: [Washington, DC] : Office of the National Coordinator for Health Information Technology, July 2023
Subject(s):: Health Services Needs and Demand
Hospitals
Routinely Collected Health Data
Social Determinants of Health
United States